OBJECTIVE: Evaluate the survival of patients who underwent pelvic exenteration (PE) with curative intent for primary persistent or recurrent cervical cancer. METHODS: We retrospectively investigated 167 consecutive patients, referred to the gynecological oncology units of 4 centers in Germany or Italy, who underwent PE. Data regarding surgery, histology, and oncologic outcomes were collected and statistically evaluated. Survival was determined from the day of exenteration until last follow-up or death. RESULTS: The median age was 51 years. Twenty-seven patients (16.2%) underwent PE owing to advanced primary tumors (group A), 34 patients (20.4%) underwent PE owing to persistent cancer after chemotherapy or chemoradiation (group B), and ...
The management of recurrent cervical cancer depends mainly on previous treatment as well as on the s...
Of 153 patients with primary or recurrent pelvic malignancy referred for consideration of exenterati...
Background: The purpose of this study was to analyse retrospectively the pooled results after pelvic...
OBJECTIVE: Evaluate the survival of patients who underwent pelvic exenteration (PE) with curative i...
Objective: Evaluate the survival of patients who underwent pelvic exenteration (PE) with curative in...
OBJECTIVE: The aim of this study was to summarize the clinical experience at our clinic with pelvic ...
Background: Pelvic exenteration (PE) for primary and recurrent cervical cancer has resulted in favor...
Objective: To analyze the clinical outcome of patients after pelvic exenteration for advanced primar...
OBJECTIVE: The aim of our study was to evaluate morbidity, mortality, and long-term survival of pati...
Objective: The aim of our study was to evaluate morbidity, mortality, and long-term survival of pati...
OBJECTIVE The aim of this study was to analyze the clinical experience and outcome of patients who h...
Objective: Our study purposewas to evaluatemorbidity and postoperative mortality in patients who und...
OBJECTIVE: Our study purpose was to evaluate morbidity and postoperative mortality in patients who ...
Purpose: Reporting the perioperative and survival outcomes of vaginectomy with respect to a matched ...
The management of recurrent cervical cancer depends mainly on previous treatment as well as on the s...
Of 153 patients with primary or recurrent pelvic malignancy referred for consideration of exenterati...
Background: The purpose of this study was to analyse retrospectively the pooled results after pelvic...
OBJECTIVE: Evaluate the survival of patients who underwent pelvic exenteration (PE) with curative i...
Objective: Evaluate the survival of patients who underwent pelvic exenteration (PE) with curative in...
OBJECTIVE: The aim of this study was to summarize the clinical experience at our clinic with pelvic ...
Background: Pelvic exenteration (PE) for primary and recurrent cervical cancer has resulted in favor...
Objective: To analyze the clinical outcome of patients after pelvic exenteration for advanced primar...
OBJECTIVE: The aim of our study was to evaluate morbidity, mortality, and long-term survival of pati...
Objective: The aim of our study was to evaluate morbidity, mortality, and long-term survival of pati...
OBJECTIVE The aim of this study was to analyze the clinical experience and outcome of patients who h...
Objective: Our study purposewas to evaluatemorbidity and postoperative mortality in patients who und...
OBJECTIVE: Our study purpose was to evaluate morbidity and postoperative mortality in patients who ...
Purpose: Reporting the perioperative and survival outcomes of vaginectomy with respect to a matched ...
The management of recurrent cervical cancer depends mainly on previous treatment as well as on the s...
Of 153 patients with primary or recurrent pelvic malignancy referred for consideration of exenterati...
Background: The purpose of this study was to analyse retrospectively the pooled results after pelvic...